Effects of xy9902 on the proliferation and differentiation of MC3T3-E1 cells

Chinese Pharmacological Bulletin

Volumn 22, Issue 5, 2006, Pages 529-532

  Hou, Jin ^a,b   Xiong, Xiao Yun ^a   Mi, Man ^b   Wang, Jie Pin ^a   Liu, Li ^a   Mei, Qi Bing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Medical College   (China)

Author keywords

Differentiation; ER; MC3T3 E1 cells; Proliferation

Indexed keywords

ALKALINE PHOSPHATASE; ANTIESTROGEN; CHINESE DRUG; ESTROGEN RECEPTOR; GENISTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; XY9902;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HORMONE SUBSTITUTION; MOUSE; NONHUMAN;

EID: 33747164814     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brzezinski A, Debi A. Phytoestrogens: The "Natural" selective estrogen receptor modulators[J]? Eur J Obstetr Gynecol Reprod Biol, 1999,85:47-51.
2. Delmas P D, Bjarnason N H, Mitlak B H, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women[J]. New Engl J Med, 1997,337:1641-7.
3. Perez P, Pulgar R, Olea-Serrano F, et al. The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups[J]. Environ Health Perspect, 1998,106(3):298-305.
4. Arcaro K F, O'Keefe P W, Yang Y, et al. Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells[J]. Toxicology, 1999,133:115-27.
5. Kanno S, Hirano S, Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells[J]. Toxicology, 2004,196:137-45.
6. Schlumpf M, Cotton B, Conscience M, et al. In vitro and in vivo estrogenicity of UV screens[J]. Environ Health Perspect, 2001, 109:239-44.
7. Kanno S, Hirano S, Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic cells[J]. Toxicology, 2004, 196:137-45.
8. Kuiper G G, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta[J]. Endocrinology, 1997,138(3):863-70.
9. Hou J, Yuan B X, He L C, et al. Evaluation of drug-muscarinic receptor affinities by using cell membrane chromatography[J]. Chin J Pharmacol Toxical, 2003,17(1):70-3.
10. Yang W, Wang Y F, Ma Z P, et al. Synthesis and structure-activity relationship of 3-arylbenzoxazines as selective β estrogen receptor agonists[J]. Bioorg Med Chem Lett, 2004,14:2327-30.
11. Asai D, Tahara Y, Nakai M, et al. Structural essentials of xenoestrogen dialkyl phthalates to bind to the estrogen receptors[J]. Toxicol Lett, 2000,118:1-8.
12. Jakacka M, Ito M, Weiss J. Estrogen receptor binding to DNA is not required for its activity through the nonclassical API pathway[J]. J Biochem, 2001,276(17):13615-21.